Innovation in Pediatric Drugs Act of 2025

3/21/2025, 1:51 PM

Summary of Bill S 705

Bill 119 s 705, also known as the Pediatric Cancer Targeted Therapy Act, aims to make important changes to the Federal Food, Drug, and Cosmetic Act in order to improve the way pediatric cancer is researched and treated. The bill specifically focuses on molecularly targeted therapies, which are treatments that target specific molecules within cancer cells.

One of the key provisions of the bill is to encourage the development of more targeted therapies for pediatric cancer. This is important because traditional cancer treatments can be harsh and have serious side effects, especially for children. By focusing on targeted therapies, the hope is that treatments can be more effective and less harmful.

The bill also includes provisions to improve the way clinical trials for pediatric cancer are conducted. This includes requiring the Food and Drug Administration (FDA) to consider the unique needs of children when reviewing new cancer treatments. Additionally, the bill aims to increase collaboration between researchers, healthcare providers, and patient advocacy groups to ensure that the best possible treatments are being developed and made available to children with cancer. Overall, Bill 119 s 705 is a bipartisan effort to improve the way pediatric cancer is researched and treated in the United States. By focusing on molecularly targeted therapies and improving the clinical trial process, the bill aims to give children with cancer better access to effective and less harmful treatments.

Current Status of Bill S 705

Bill S 705 is currently in the status of Bill Introduced since February 25, 2025. Bill S 705 was introduced during Congress 119 and was introduced to the Senate on February 25, 2025.  Bill S 705's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1347) as of February 25, 2025

Bipartisan Support of Bill S 705

Total Number of Sponsors
4
Democrat Sponsors
4
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
0
Republican Cosponsors
1
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 705

Primary Policy Focus

Health

Alternate Title(s) of Bill S 705

A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.
Start holding our government accountable!

Comments